z‐Wire: A Microscaffold That Supports Guided Tissue Assembly and Intramyocardium Delivery for Cardiac Repair

2020 ◽  
Vol 9 (14) ◽  
pp. 2000358
Author(s):  
Luis Eduardo Portillo‐Esquivel ◽  
Vibudha Nanduri ◽  
Feng Zhang ◽  
Wenbin Liang ◽  
Boyang Zhang
Keyword(s):  
Cardiac Repair ◽  
Tissue Assembly

scholarly journals Smart Scaffolds: z‐Wire: A Microscaffold That Supports Guided Tissue Assembly and Intramyocardium Delivery for Cardiac Repair (Adv. Healthcare Mater. 14/2020)

2020 ◽  
Vol 9 (14) ◽  
pp. 2070044
Author(s):  
Luis Eduardo Portillo‐Esquivel ◽  
Vibudha Nanduri ◽  
Feng Zhang ◽  
Wenbin Liang ◽  
Boyang Zhang
Keyword(s):  
Cardiac Repair ◽  
Tissue Assembly

The temporary stent as a bridge to congenital cardiac repair

2012 ◽  
Vol 60 (S 01) ◽  
Author(s):  
A Kroener ◽  
U Trieschmann ◽  
M Emmel ◽  
K Brockmeier ◽  
N Sreeram ◽  
...  
Keyword(s):  
Cardiac Repair ◽  
Temporary Stent

Selection of tissue engineering matrix for cardiac repair medicine

2004 ◽  
Vol 52 (S 1) ◽  
Author(s):  
MN Giraud ◽  
H Tevaearai ◽  
C Receputo ◽  
U Nydegger ◽  
T Carrel
Keyword(s):  
Tissue Engineering ◽  
Cardiac Repair ◽  
Selection Of

Breakthrough Regenerative Cardiopoietic Stem Cells and Related Technologies in the Field of Cardiovascular Medicine – From Bench to Bedside

2012 ◽  
Vol 7 (1) ◽  
pp. 14
Author(s):  
Christian Homsy ◽  
Keyword(s):  
Stem Cells ◽  
Cell Therapy ◽  
Progenitor Cells ◽  
Cardiac Disease ◽  
Cardiac Tissue ◽  
Cardiac Repair ◽  
Cardiac Diseases ◽  
Cardiac Progenitor Cells ◽  
Biotechnology Company ◽  
Cardiovascular Medicine

The scale of cardiac diseases, and in particular heart failure and acute myocardial infarction, emphasises the need for radically new approaches, such as cell therapy, to address the underlying cause of the disease, the loss of functional myocardium. Stem cell-based therapies, whether through transplanted cells or directing innate repair, may provide regenerative approaches to cardiac diseases by halting, or even reversing, the events responsible for progression of organ failure. Cardio3 BioSciences, a leading Belgian biotechnology company focused on the discovery and development of regenerative and protective therapies for the treatment of cardiac disease, was founded in this context in 2004. The company is developing a highly innovative cell therapy approach based on a platform designed to reprogramme the patient’s own stem cells into cardiac progenitor cells. The underlying rationale behind this approach is that, in order to reconstruct cardiac tissue, stem cells need to be specific to cardiac tissue. The key is therefore to provide cardiac-specific progenitor cells to the failing heart to induce cardiac repair.

ENDOGENOUS AND EXOGENOUS SOURCES OF CARDIAC REPAIR IN MAMMALS

2018 ◽  
Vol 26 (2) ◽  
pp. 42-47
Author(s):  
T.V. Lipina ◽  
◽  
A.V. Komova ◽  
S.Y. Sosnovskaya ◽  
N.V. Kosheleva ◽  
...  
Keyword(s):  
Cardiac Repair
Sign in / Sign up

Export Citation Format

Share Document